Related Experiment Video
Updated: Jun 21, 2026

Analytical Techniques for Assaying Nitric Oxide Bioactivity
Published on: June 18, 2012
Sodium-nitroprusside-induced cyanide toxicity in pediatric patients
Christopher Thomas1, Lindsay Svehla, Brady S Moffett
1Texas Children's Hospital, Department of Pharmacy, 6621 Fannin Street, MC 2-2510, Houston, TX 77030, USA. bsmoffet@texaschildrenshospital.org
Background:
Sodium nitroprusside (SNP) is often used as a continuous infusion intravenous vasodilator in pediatric patients. However, cyanide toxicity can occur with SNP therapy. Scant literature is available determining the safety of SNP therapy, the incidence of cyanide toxicity or the risk factors for cyanide toxicity in pediatric patients.
Objective:
To review the literature concerning the safety of intravenous SNP with regard to cyanide toxicity in the pediatric patient population.
Methods:
A MedLine search was used to identify articles pertaining to SNP therapy and cyanide toxicity in pediatric patients.
Conclusions:
Sodium nitroprusside seems to be safe when used in critically ill pediatric patients. Cyanide toxicity may occur in patients with specific risk factors. Routine monitoring of cyanide levels may not be warranted.
Related Concept Videos
Antihypertensive Drugs: Vasodilators
2° Amines to N-Nitrosamines: Reaction with NaNO2
Pharmacokinetics in Pediatric Patients: Drug Excretion
Drug Toxicity: Dose-Dependent Reactions
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Drug Delivery: Enteral Route
Drugs in...